Johnson & Johnson reveals its Covid vaccine is 66% effective in clinical trial
Johnson and Johnson’s coronavirus vaccine is 66 per cent effective against the disease, early trial results reveal. And it was shown to prevent severe cases of the virus in 86 per cent of cases. The jab made by Janssen – the Belgian arm of the US pharmaceutical giant – uses similar technology to the Oxford … Read more